-
Choosing Frontline Therapy in Metastatic Disease
John L. Marshall, MD, and Fadi Braiteh, MD, outline the factors they consider when deciding on a frontline treatment strategy in patients with metastatic pancreatic cancer.
Uncategorized
-
Expert Highlights Progress With Molecular Biomarkers in GI Cancers
Michael J. Pishvaian, MD, discussed expanded testing for biomarkers, using liquid biopsies to predict response to treatment, and the importance of identifying increasingly specific subsets of GI cancers to make treatment decisions.
Category: News
-
Recent Advances in Pancreatic Cancer Research
John L. Marshall, MD; Kenneth H. Yu, MD; and Fadi Braiteh, MD, provide an overview of recent advances in the field of pancreatic cancer, including an increased understanding of the tumor microenvironment.
Category: News
-
Expanding the Armamentarium in Metastatic Liver Cancer
This OncLive® global Peer Exchange® panel of experts in liver cancer will discuss the best practices with the currently available therapies in the setting of metastatic disease. We will also bring you up to speed on emerging therapies and novel combination therapies.
Category: News
-
Dr. He on the Future of Precision Medicine in GI Malignancies
Aiwu Ruth He, MD, PhD, discusses the future of precision medicine in gastrointestinal malignancies.
Category: News
-
Colorectal and Pancreatic Cancer Vaccine Candidate Launches Clinical Study
Immunotherapy candidate CV301 and durvalumab, IMFINZI, which is a PD-L1 inhibitor combination for patients with metastatic colorectal or pancreatic cancers.
Category: News
-
Gastrointestinal Cancers Entering Age of Precision Medicine
Aiwu Ruth He, MD, PhD, discusses the future of precision medicine in gastrointestinal cancers.
Category: News
-
Dr. Pishvaian on the Future of Entrectinib in Pancreatic Cancer
Michael Pishvaian, MD, PhD, discusses the future of entrectinib in the treatment of patients with pancreatic cancer.
Category: News
-
Celebrating the End of Chemotherapy Can Isolate Those Not So Lucky
Dr John Marshall on how a recent symposium opened his eyes to the unintended effects of a bell-ringing ceremony at his practice.
Category: News
-
Dr. Marshall on Single-Agent and Combination Immunotherapy Applications in MSI-H mCRC
John L. Marshall, MD, discusses the progression of immunotherapy in colon cancer.
Category: News